Get the Stockscreener App
8.71
1.80%
-0.16
After Hours:
8.76
0.05
+0.57%
Brainsway Ltd Adr stock is traded at $8.71, with a volume of 12,443.
It is down -1.80% in the last 24 hours and down -0.57% over the past month.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
See More
Previous Close:
$8.87
Open:
$8.84
24h Volume:
12,443
Relative Volume:
0.24
Market Cap:
$170.23M
Revenue:
$38.63M
Net Income/Loss:
$1.50M
P/E Ratio:
92.36
EPS:
0.0943
Net Cash Flow:
$5.97M
1W Performance:
-3.44%
1M Performance:
-0.57%
6M Performance:
-19.80%
1Y Performance:
+59.82%
1-Day Range:
$8.70
$8.854
1-Week Range:
$8.605
$9.1549
52-Week Range:
$5.13
$11.79
Brainsway Ltd Adr Stock (BWAY) Company Profile
Compare BWAY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BWAY
Brainsway Ltd Adr
|
8.71 | 170.23M | 38.63M | 1.50M | 5.97M | 0.0943 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Brainsway Ltd Adr Stock (BWAY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-16-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Mar-03-22 | Initiated | Loop Capital | Buy |
| Jul-19-21 | Initiated | H.C. Wainwright | Buy |
| Apr-20-21 | Initiated | Northland Capital | Outperform |
| May-13-19 | Initiated | Cantor Fitzgerald | Overweight |
| May-13-19 | Initiated | Ladenburg Thalmann | Buy |
| May-13-19 | Initiated | Oppenheimer | Outperform |
| May-13-19 | Initiated | Raymond James | Outperform |
View All
Brainsway Ltd Adr Stock (BWAY) Latest News
BWAY Drops 15% in Four Days: How to Play the Stock Before Earnings? - Zacks Investment Research
Brainsway (BWAY) Is a Great Choice for 'Trend' Investors, Here's Why - Nasdaq
Brainsway Ltd. Sponsored ADR (BWAY) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
Zacks.com Highlights: SB Financial Group, First Community, StoneX Group, Byrna Technologies, and BrainsWay - The Union Journal
Zacks.com featured highlights include SB Financial Group, First Community, StoneX Group, Byrna Technologies and BrainsWay - Yahoo Finance
Brainsway (BWAY) is on the Move, Here's Why the Trend Could be Sustainable - MSN
Zacks.com featured highlights include Mission Produce, Accel Entertainment, BrainsWay and First Bank - Yahoo Finance
Zacks.com featured highlights include Bridgewater Bancshares, Eastern Bankshares and BrainsWay - Yahoo Finance
Outbrain (OB) and Brainsway (BWAY) Are Aggressive Growth Stocks - Nasdaq
Brainsway Ltd. Sponsored ADR (BWAY) Soars to 52-Week High, Time to Cash Out? - MSN
Brainsway (BWAY) Moves 8.0% Higher: Will This Strength Last? - MSN
Bear of the Day: Baxter (BAX) - Yahoo Finance
Wall Street Analysts Think Brainsway (BWAY) Could Surge 38.83%: Read This Before Placing a Bet - MSN
New Strong Buy Stocks for January 14th - MSN
Recent Price Trend in Brainsway (BWAY) is Your Friend, Here's Why - Yahoo Finance
Earnings Estimates Rising for Brainsway (BWAY): Will It Gain? - MSN
Are Medical Stocks Lagging Brainsway (BWAY) This Year? - Yahoo Finance
Brainsway (BWAY) Soars 14.5%: Is Further Upside Left in the Stock? - MSN
BrainsWay Reports Promising Feasibility Data Showing Pain Reduction with Deep TMS Therapy - GlobeNewswire Inc.
Brainsway stock soars to 52-week high, hits $10.75 - Investing.com
Solventum Q3 Earnings Likely to Reflect Declining Volume Trend - Yahoo Finance
Is Brainsway (BWAY) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Wall Street Analysts Believe Brainsway (BWAY) Could Rally 32.01%: Here's is How to Trade - Yahoo Finance
Brainsway stock soars to 52-week high, hits $10.01 - Investing.com
Brainsway Stock Hits 52-Week High at $9.72 Amidst 143% Annual Surge - Investing.com
Brainsway Ltd. Sponsored ADR (BWAY) Hits Fresh High: Is There Still Room to Run? - Nasdaq
BrainsWay secures $20 million in private investment By Investing.com - Investing.com
5 Stocks With Recent Price Strength to Enhance Your Portfolio - Yahoo Finance
Is Butterfly Network (BFLY) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Mexico Transcranial Magnetic Stimulation System Market Size & Outlook, 2030 - Grand View Research
Here's Why Brainsway Ltd. Sponsored ADR (BWAY) is a Great Momentum Stock to Buy - Yahoo Finance
5 Best Small-Cap Stocks to Benefit From Interest Rate Cuts - Yahoo Finance
Japan Transcranial Magnetic Stimulation System Market Size & Outlook, 2030 - Grand View Research
Australia Transcranial Magnetic Stimulation System Market Size & Outlook, 2030 - Grand View Research
Saudi Arabia Transcranial Magnetic Stimulation System Market Size & Outlook, 2030 - Grand View Research
Germany Transcranial Magnetic Stimulation System Market Size & Outlook, 2030 - Grand View Research
3 Growth Stocks Under $10 With Breakout Potential - Barchart.com
New Strong Buy Stocks for March 11th - Zacks Investment Research
Brainsway Ltd. Sponsored ADR (BWAY) Is a Great Choice for 'Trend' Investors, Here's Why - Yahoo Finance
New Strong Sell Stocks for January 19th - Yahoo Finance
BrainsWay Reports Open Market Stock Purchase by Board Member Yossi Ben Shalom - StockTitan
Brainsway Ltd Adr Stock (BWAY) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):